Press enter or spacebar to select a desired language.
Press enter or spacebar to select a desired language.

Choose Queensland for your next clinical trial

Value

Value

Cost-effective clinical trials

It is up to 60% cheaper to conduct clinical trials in Australia compared to the USA.

Commercial sponsors take advantage of competitive clinical trial costs in Queensland. Learn more about research and development tax incentives.

Australia is cheaper

Research and Development Tax Incentive Program

Eligible companies can take advantage of the Research and Development (R&D) Tax Incentive program with a cash refund of up to 43.5% on qualifying* R&D expenditure. The R&D Tax Incentive program provides targeted R&D tax offsets to encourage more companies to engage in research in Australia. The R&D tax incentive has two core components. Companies with an annual turnover of $20 million or less. Companies with an annual turnover of $20 million or more. Unlike similar programs in other countries, there is no requirement for companies in Australia to demonstrate year-on-year growth in their R&D expenditure to claim a tax benefit. It’s also not a requirement for the intellectual property from eligible R&D projects to be held in Australia. Learn more about the Research and Development Tax Incentive program.

Learn about the R&D Tax Incentive Program

Eligibility

Generally, activities conducted in Australia during early stage development or clinical trials (phases 0/I, II and III) are likely to meet the eligibility criteria.

There is no Investigational New Drug (IND) requirement in Australia allowing rapid entry into clinical trials under the Clinical Trials Notification scheme (CTN). The CTN is administered by the Therapeutic Goods Administration (TGA).